Tag: newswire

Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and Regulatory Evaluation

Exclusive concierge-style relationship program combines bespoke matchmaking, executive coaching, and international lifestyle support

Partnership combines Cognizant’s global AI engineering capabilities with Gulf Edge’s sovereign digital infrastructure to capture the region’s growing demand for secure, scalable AI solutions.

Additional waterfront parkland opens on Toronto’s newest island, marking a major milestone in one of North America’s most ambitious waterfront transformations

ST. MICHAEL, Barbados, July 23, 2026 (GLOBE NEWSWIRE) -- Inspirado na mais recente onda de dramas de resorts de luxo, o Royalton Hotels & Resorts está dando vida à fantasia com uma experiência exclusiva, onde o serviço personalizado, o luxo atemporal e a narrativa inesquecível são o centro das atenções.

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Pelican Acquisition II Corporation (NASDAQ: PLCIU) (the “Company”), a Cayman Islands exempted company, announced that it priced its initial public offering of 7,500,000 units at $10.00 per unit on July 23, 2026. The units will be listed on the Nasdaq Capital Market (“NASDAQ”) and are expected to trade under the ticker symbol “PLCIU” beginning on July 24, 2026. Each unit consists of one ordinary share of the Company and one right, with each right entitling the holder thereof to receive one-tenth (1/10) of one ordinary share upon the consummation of an initial business combination.  

Cheyenne, Wyoming, July 23, 2026 (GLOBE NEWSWIRE) -- Core Axis, a health brand founded by MC Bio-Logic LLC, announces the upcoming launch of its daily supplement protocol developed with Hashimoto's thyroiditis in mind. Hashimoto's thyroiditis is the autoimmune condition that affects an estimated five million Americans and remains the leading cause of hypothyroidism in the United States. Designed using evidence-based ingredient selection and clinically relevant dosages, the new protocol addresses nutritional factors relevant to individuals with autoimmune thyroid conditions rather than providing general thyroid support. The company is now inviting individuals to join its early access waitlist ahead of the official product launch.

Phoenix, July 23, 2026 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the first quarter ended June 27, 2026 on Thursday, July 30, 2026 after the close of market. Senior management will discuss the results in a live webcast the following day, Friday, July 31, 2026 at 1:00 p.m. Eastern Time.